IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation

Giuliana Guggino, Francesco Ciccia, Andrea L. Neimann, Alexander A. Aksenov, Carles Ubeda, Julia Manasson, Leopoldo N. Segal, Jose C. Clemente, Michelle H. Badri, Adriana Heguy, Roxana Coras, Matthew Stapylton, David S. Wallach, Parvathy V. Girija, Drew R. Jones, Gary Solomon, Francesco Ciccia, Adriana Heguy, Monica Guma, Richard BonneauGary Solomon, Pieter C. Dorrestein, Jose U. Scher, Soumya M. Reddy

Risultato della ricerca: Articlepeer review

16 Citazioni (Scopus)

Abstract

To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.
Lingua originaleEnglish
Numero di pagine41
RivistaARTHRITIS & RHEUMATOLOGY
Stato di pubblicazionePublished - 2020

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2723???
  • ???subjectarea.asjc.2700.2745???
  • ???subjectarea.asjc.2400.2403???

Fingerprint

Entra nei temi di ricerca di 'IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation'. Insieme formano una fingerprint unica.

Cita questo